Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical and Health Product Manufacturing and Sales Business	523.14M	-	-	-	-
Active Pharmaceutical Ingredient (API) Manufacturing and Sales Business	3.73M	-	-	-	-
Other Operations	17.63M	-	-	-	2.29M
Offset of Business Segment	-206.82M	-	-	-	-
Production and Sales of Western Medicine	-	-	-	-	13.63M
Production and Sales of Traditional Chinese Medicine	-	-	-	-	284.86M
Medicine Manufacturing	-	-	384.66M	346.53M	-
Unallocated Others	-	-	19.98M	4.00M	-
Total	337.67M	-	404.65M	350.53M	300.77M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	337.67M	343.21M	404.65M	350.53M	300.77M
Total	337.67M	343.21M	404.65M	350.53M	300.77M

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error